Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Nephros stock
Learn how to easily invest in Nephros stock.
Nephros Inc is a medical instruments & supplies business based in the US. Nephros shares (NEPH) are listed on the NASDAQ and all prices are listed in US Dollars. Nephros employs 34 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Nephros
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NEPH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Nephros stock price (NASDAQ: NEPH)Use our graph to track the performance of NEPH stocks over time.
Nephros shares at a glance
|Latest market close||$1.47|
|52-week range||$1.51 - $11.67|
|50-day moving average||$2.56|
|200-day moving average||$5.32|
|Wall St. target price||$7.63|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.55|
Buy Nephros shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Nephros stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Nephros price performance over time
|1 week (2022-06-24)||-4.55%|
|1 month (2022-06-01)||-20.11%|
|3 months (2022-03-28)||N/A|
|6 months (2021-12-31)||-75.08%|
|1 year (2021-07-01)||-85.31%|
|2 years (2020-07-01)||-81.78%|
|3 years (2019-07-01)||145.00%|
|5 years (2017-06-29)||535.81%|
|Revenue TTM||$9.9 million|
|Gross profit TTM||$5.7 million|
|Return on assets TTM||-19.69%|
|Return on equity TTM||-36.61%|
|Market capitalisation||$15.9 million|
TTM: trailing 12 months
Nephros share dividends
We're not expecting Nephros to pay a dividend over the next 12 months.
Have Nephros's shares ever split?
Nephros's shares were split on a 1:9 basis on 9 July 2019. So if you had owned 9 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Nephros shares – just the quantity. However, indirectly, the new 800% higher share price could have impacted the market appetite for Nephros shares which in turn could have impacted Nephros's share price.
Nephros share price volatility
Over the last 12 months, Nephros's shares have ranged in value from as little as $1.51 up to $11.67. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nephros's is 1.2731. This would suggest that Nephros's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Frequently asked questionsWhat percentage of Nephros is owned by insiders or institutions?
Currently 10.147% of Nephros shares are held by insiders and 46.895% by institutions. How many people work for Nephros?
Latest data suggests 34 work at Nephros. When does the fiscal year end for Nephros?
Nephros's fiscal year ends in December. Where is Nephros based?
Nephros's address is: 380 Lackawanna Place, South Orange, NJ, United States, 07079 What is Nephros's ISIN number?
Nephros's international securities identification number is: US6406714005 What is Nephros's CUSIP number?
Nephros's Committee on Uniform Securities Identification Procedures number is: 640671103
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert